leptospirosi
widespread
zoonot
infect
primarili
affect
resid
tropic
region
caus
infect
anim
human
temper
region
well
agent
leptospirosi
compris
sever
member
genu
leptospira
also
includ
nonpathogen
saprophyt
speci
leptospirosi
vari
sever
mild
nonspecif
ill
sever
diseas
includ
multiorgan
failur
widespread
endotheli
damag
hemorrhag
begin
investig
pathogen
leptospir
affect
endotheli
cell
compar
respons
two
endotheli
cell
line
infect
pathogen
versu
nonpathogen
leptospir
microarray
analys
suggest
pathogen
l
interrogan
nonpathogen
l
biflexa
trigger
chang
express
gene
whose
product
involv
cellular
architectur
interact
matrix
chang
opposit
direct
infect
l
biflexa
primarili
predict
increas
maintain
cell
layer
integr
l
interrogan
lead
primarili
chang
predict
disrupt
cell
layer
integr
neither
bacteri
strain
caus
necrosi
apoptosi
cell
even
prolong
incub
pathogen
l
interrogan
howev
result
signific
disrupt
endotheli
cell
layer
assess
microscopi
abil
bacteria
cross
cell
layer
disrupt
endotheli
layer
integr
abrog
addit
endotheli
protect
drug
lisinopril
physiolog
relev
concentr
result
suggest
adhes
l
interrogan
endotheli
cell
bacteria
may
disrupt
endotheli
barrier
function
promot
dissemin
bacteria
contribut
sever
diseas
manifest
addit
supplement
antibiot
therapi
lisinopril
deriv
endotheli
protect
activ
may
decreas
sever
leptospirosi
citat
martinezlopez
dg
fahey
coburn
j
respons
human
endotheli
cell
pathogen
nonpathogen
leptospira
speci
plo
negl
trop
di
leptospirosi
geograph
widespread
zoonosi
emerg
signific
public
health
problem
urban
slum
particularli
tropic
infect
caus
speci
spirochet
belong
genu
leptospira
serovar
leptospira
distribut
among
pathogen
nonpathogen
speci
pathogen
differ
strain
vari
consider
depend
host
speci
age
infect
serovar
spirochet
mode
entri
mucou
membran
cut
abras
skin
upon
entri
organ
travel
bloodstream
multipl
site
may
caus
liver
kidney
damag
mening
varieti
inflammatori
condit
host
surviv
acut
infect
leptospir
persist
proxim
renal
tubul
week
month
protect
antibodi
caus
littl
inflamm
bacteria
shed
urin
anim
urin
contamin
water
primari
sourc
human
exposur
although
littl
known
leptospira
speci
establish
infect
host
adhes
host
cell
surfac
extracellular
matrix
ecm
pathogen
often
first
critic
step
initi
infect
sever
group
investig
adhes
leptospira
interrogan
endotheli
fibroblast
kidney
epitheli
monocytemacrophag
cell
line
cultur
vitro
like
pathogen
leptospir
attach
sever
differ
type
mammalian
receptor
establish
infect
fact
infecti
strain
leptospira
shown
adher
ecm
compon
includ
collagen
type
iv
fibronectin
laminin
also
plasma
protein
fibrinogen
adhes
sever
ecm
compon
mediat
least
part
liga
ligb
protein
group
addit
relat
protein
identifi
homolog
laminin
bind
protein
sever
studi
shown
adhes
pathogen
mammalian
cell
provok
multipl
chang
physiolog
andor
gene
express
host
hostpathogen
interact
defin
diseas
clearli
complex
microarray
power
tool
explor
hostpathogen
interact
analyz
transcript
profil
host
cell
pathogen
although
document
temperatur
osmolar
alter
leptospir
gene
express
previous
publish
research
focus
mammalian
cell
respons
bacteria
understand
human
endotheli
cell
alter
gene
express
respons
incub
differ
strain
leptospira
human
gene
array
probe
cdna
deriv
rna
purifi
infect
cell
uninfect
control
studi
discuss
global
analysi
gene
express
allow
us
gain
insight
host
specif
respons
infect
pathogen
leptospira
human
microvascular
endotheli
cell
line
dermal
origin
obtain
dr
ade
center
diseas
control
prevent
atlanta
georgia
cultur
endotheli
basal
medium
clonet
san
diego
ca
supplement
heatinactiv
fetal
bovin
serum
hyclon
logan
ut
mgml
hydrocortison
sigmaaldrich
st
loui
mo
ngml
epiderm
growth
factor
sigmaaldrich
immort
human
macrovascular
endotheli
cell
line
kindli
provid
dr
cj
edgel
univers
north
carolina
chapel
hill
nc
grown
dulbecco
modifi
eagl
medium
high
glucos
supplement
heatinactiv
fetal
bovin
serum
gibco
grand
island
ny
hat
media
supplement
sigmaaldrich
cell
line
cultur
medium
recommend
supplier
humidifi
atmospher
co
cell
media
supplement
uml
penicillin
mgml
streptomycin
mm
lglutamin
routin
propag
cell
use
experiment
infect
leptospira
strain
cultur
without
antibiot
role
proteoglycan
endotheli
cell
respons
l
interrogan
test
base
previous
publish
protocol
briefli
chondroitin
sulfat
b
shown
bind
l
interrogan
competit
inhibit
l
interrogan
mammalian
cell
test
abil
inhibit
endotheli
cell
respons
bacteria
describ
addit
inhibit
proteoglycan
synthesi
bxylosid
also
decreas
l
interrogan
attach
mammalian
cell
test
effect
control
includ
chondroitin
sulfat
l
interrogan
bind
sugar
analog
agalactosid
affect
proteoglycan
synthesi
refer
strain
leptospira
biflexa
serovar
patoc
obtain
american
type
cultur
collect
atcc
manassa
va
nonpathogen
speci
l
interrogan
serovar
canicola
pathogen
strain
atcc
strain
obtain
atcc
dr
richard
zuerner
usda
ame
ia
respect
l
interrogan
serovar
copenhageni
pathogen
strain
design
fiocruz
provid
dr
david
haak
ucla
lo
angel
ca
bacteri
strain
maintain
ambient
air
bacteria
util
studi
low
passag
supplier
passag
cultur
emjh
medium
supplement
mgml
rabbit
serum
sigmaaldrich
experi
bacteria
radiolabel
addit
cystein
plu
methionin
medium
describ
previous
bacteria
enumer
use
petroffhauss
count
chamber
dark
field
microscopi
mammalian
cell
plate
tissu
cultur
flask
bd
falcon
bedford
grown
higher
confluenc
cell
reach
desir
confluenc
monolay
wash
pb
cell
lift
plastic
cultur
flask
edta
pb
done
allow
access
bacteria
endotheli
cell
surfac
receptor
normal
involv
attach
substratum
ie
receptor
bacteria
may
encount
penetr
vasculatur
addit
approach
minim
degrad
mrna
occur
harvest
adher
cell
lift
cell
spun
minut
rpm
resuspend
cell
cultur
medium
without
antibiot
enumer
use
hemocytomet
count
chamber
cell
per
sampl
incub
suspens
either
l
biflexa
serovar
patoc
l
interrogan
serovar
canicola
without
bacteria
h
h
room
temperatur
cell
medium
without
antibiot
moi
multipl
infect
use
bacteria
per
mammalian
cell
incub
cell
wash
phosphat
buffer
salin
pb
harvest
rna
isol
rna
purifi
use
rneasi
kit
qiagen
valencia
ca
dnase
digest
accord
manufactur
manual
qualiti
rna
check
use
bioanalyz
agil
santa
clara
ca
human
heebo
human
exon
evid
base
oligonucleotid
array
consist
probe
repres
known
gene
purchas
microarray
inc
nashvil
tn
mg
total
rna
uninfect
control
infect
sampl
use
gener
cdna
label
aminoallyl
aa
dutp
revers
transcript
reaction
use
anchor
oligo
dt
primer
purifi
aadutplabel
cdna
coupl
ml
nahco
either
nhsester
dye
cydy
label
cdna
purifi
use
cyscrib
gfx
column
amersham
bioscienc
piscataway
nj
two
differ
label
cdna
mix
hybrid
use
pronto
microarray
hybrid
kit
hybrid
chamber
corn
corn
ny
array
slide
hr
accord
manufactur
instruct
seri
wash
use
buffer
provid
kit
slide
spun
dri
scan
two
laser
channel
scanarray
scanner
packard
bioscienc
meriden
ct
leptospirosi
widespread
zoonot
infect
primarili
affect
resid
tropic
region
seen
occasion
temper
region
well
leptospirosi
vari
sever
mild
nonspecif
ill
sever
diseas
includ
multiorgan
failur
widespread
endotheli
damag
hemorrhag
investig
pathogen
leptospir
affect
endotheli
cell
compar
respons
two
endotheli
cell
line
infect
pathogen
versu
nonpathogen
leptospir
analys
suggest
pathogen
l
interrogan
nonpathogen
l
biflexa
caus
chang
express
gene
whose
product
involv
cellular
architectur
interact
matrix
chang
opposit
direct
infect
l
biflexa
primarili
maintain
cell
layer
integr
l
interrogan
disrupt
cell
layer
fact
l
interrogan
caus
signific
disrupt
endotheli
cell
layer
damag
could
abrog
endotheli
protect
drug
lisinopril
result
suggest
l
interrogan
bind
endotheli
cell
disrupt
endotheli
barrier
function
may
promot
dissemin
bacteria
contribut
sever
diseas
manifest
disrupt
may
slow
endothelialprotect
drug
decreas
damag
leptospirosi
endotheli
cell
respons
leptospira
wwwplosntdsorg
imag
overlaid
analyz
use
imagen
biodiscoveri
el
segundo
ca
raw
gene
express
import
imagen
genesift
genesifternet
vizx
lab
seattl
wa
analysi
data
biolog
replic
experi
normal
use
lowess
normal
median
raw
intens
spot
sampl
array
ratio
two
fluoresc
intens
spot
reflect
ratio
gene
express
infect
uninfect
sampl
gene
consid
induc
repress
ratio
infecteduninfect
least
fold
increas
decreas
p
valu
student
twotail
test
analysi
involv
one
time
point
condit
one
way
anova
test
perform
microarray
data
deposit
geo
archiv
access
number
cell
seed
tissu
cultur
treat
glass
slide
bd
falcon
grown
describ
cell
reach
confluenc
monolay
wash
three
time
pb
medium
without
antibiot
ad
four
compart
slide
inocul
bacteria
moi
either
l
biflexa
serovar
patoc
l
interrogan
serovar
canicola
remain
four
well
left
uninfect
serv
neg
control
case
parallel
experi
perform
use
cell
plate
coverslip
well
cultur
dish
allow
centrifug
facilit
bacterialendotheli
cell
contact
end
incub
h
h
h
slide
wash
three
time
pb
fix
wtvol
paraformaldehyd
pb
room
temperatur
min
cell
permeabil
triton
pb
wash
three
time
pb
block
overnight
hepe
buffer
salin
hb
bovin
serum
albumin
bsa
next
day
slide
wash
pb
incub
fresh
block
solut
room
temperatur
block
layer
probe
either
rabbit
antil
interrogan
gift
dr
richard
zuerner
usda
ame
ia
dilut
antil
biflexa
antiserum
biogenesi
inc
brentwood
nh
dilut
follow
antirabbit
iggtritc
conjug
plu
phalloidinfitc
uml
stain
filament
actin
repeat
wash
pb
chamber
remov
slide
prolong
antifad
invitrogen
carlsbad
ca
use
mount
coverslip
two
differ
microscop
two
differ
institut
use
throughout
cours
work
institut
one
imag
captur
use
zeiss
axioplan
microscop
digit
chargecoupl
devic
camera
hamamatsu
hamamatsu
citi
japan
coloc
fluoresc
label
done
use
voloc
softwar
improvis
inc
lexington
second
institut
zeiss
axioimag
axiocam
hrc
camera
nuanc
multispectr
imag
system
softwar
cri
inc
woburn
use
endotheli
cell
line
hmec
plate
mm
porescm
polyest
transwel
insert
corn
cultur
describ
reach
confluenc
assess
lack
penetr
fluoresc
dye
fitcdextran
loss
penetr
l
biflexa
serovar
patoc
monolay
wash
pb
cell
medium
without
antibiot
ad
insert
well
insert
without
cell
use
control
experi
bacteria
ad
moi
allow
reliabl
enumer
bacteria
cross
cell
layer
membran
without
cell
earli
time
point
ml
insert
well
taken
h
h
h
h
h
h
h
addit
nonpathogen
strain
patoc
pathogen
canicola
leptospira
interrogan
serovar
copenhageni
also
use
analyz
migrat
leptospir
cell
monolay
motil
leptospir
count
darkfield
microscopi
use
petroffhauss
chamber
data
shown
time
point
bacteria
motil
hr
progress
decreas
l
biflexa
motil
determin
whether
bacteria
affect
viabil
endotheli
cell
four
method
use
first
adher
edtalift
endotheli
cell
infect
moi
wash
incub
vital
dye
celltrack
green
ctcmfda
mm
plu
dapi
mgml
molecular
probe
part
invitrogen
eugen
hour
co
sampl
mount
view
use
zeiss
axioplan
microscop
describ
live
cell
bright
green
cytoplasm
dead
cell
bright
blue
nuclei
enumer
least
three
field
per
sampl
least
three
independ
experi
second
cell
stain
use
vybrant
apoptosi
assay
kit
molecular
probe
stain
annexin
v
membran
permeabl
third
apobrdu
tunel
kit
also
molecular
probe
use
second
tunelbas
kit
alert
dna
fragment
kit
clontech
laboratori
inc
mountain
view
ca
also
use
method
two
three
cell
also
assess
use
fluoresc
microscopi
final
cell
harvest
dna
purifi
analyz
fragment
assess
apoptosi
use
convent
agaros
gel
electrophoresi
identifi
statist
signific
reproduc
chang
endotheli
cell
gene
express
incub
bacteri
strain
compar
uninfect
control
data
analyz
use
webgestalt
identifi
mammalian
cell
gene
whose
product
compris
function
pathway
multipl
compon
show
alter
gene
express
tabl
four
pathway
show
intern
consist
chang
gene
express
kegg
focal
adhes
regul
actin
cytoskeleton
leukocyt
transendotheli
migrat
ecmreceptor
interact
pathway
consid
togeth
number
gene
encod
protein
whose
function
particip
aspect
cell
biolog
common
pathway
actin
microfila
one
three
major
compon
cellular
cytoskeleton
cytoskeleton
particip
maintain
adhes
commun
extracellular
matrix
cell
migrat
divis
signal
bactin
actb
mrna
decreas
respons
l
interrogan
increas
respons
l
biflexa
compar
uninfect
control
cell
tabl
guanin
nucleotidebind
protein
subunit
mediat
activ
small
gtpase
rhoa
activ
control
assembl
focal
adhes
actin
format
stress
fiber
although
rhoa
differenti
regul
respons
bacteria
rho
gtpase
activ
protein
differenti
express
follow
pattern
gene
downregul
respons
pathogen
leptospir
comparison
uninfect
control
upregul
respons
nonpathogen
effect
decreas
may
decreas
stimul
rho
chang
express
sever
addit
gene
consist
chang
cellular
architectur
result
leptospir
infect
endotheli
cell
exampl
decreas
mrna
radixin
rdx
protein
link
actin
cytoskeleton
plasma
caveolin
coupl
integrin
raserk
pathway
titin
ecm
compon
laminin
integrin
subunit
v
b
tabl
seen
cell
infect
l
interrogan
canicola
compar
uninfect
control
contrast
l
biflexa
patoc
caus
increas
mrna
level
gene
infect
cell
vs
uninfect
control
tabl
togeth
gene
express
pattern
consist
hypothesi
one
effect
l
interrogan
serovar
canicola
promot
actin
remodel
detach
cell
ecm
fundament
stage
pathogenesi
leptospira
infect
abil
bacteria
cross
mucou
membran
underli
epitheli
barrier
well
endotheli
cell
barrier
dissemin
differ
organ
although
leptospira
speci
endotheli
cell
plate
tissu
cultur
treat
glass
chamber
slide
allow
reach
near
confluenc
assess
visual
bacteria
ad
moi
incub
endotheli
cell
hour
wash
fix
slide
stain
phalloidinfitc
illumin
f
actin
plu
antileptospira
antibodi
follow
tritcconjug
secondari
antibodi
retract
cell
bodi
respons
l
interrogan
canicola
l
biflexa
patoc
evid
particularli
hr
infect
brighter
stain
round
retract
cell
fitcphalloidin
may
due
disorgan
cellular
architectur
without
complet
depolymer
actin
increas
depth
decreas
area
cytoplasm
would
appear
concentr
therefor
brighter
chang
endotheli
cell
morpholog
evid
earlier
time
point
cell
l
interrogan
bacteria
associ
one
higher
magnif
micrograph
l
interrogan
canicola
infect
cell
includ
bacteria
small
view
field
endotheli
cell
provid
inform
integr
monolay
micrograph
repres
multipl
independ
experi
l
interrogan
copenhageni
caus
essenti
chang
endotheli
cell
morpholog
l
interrogan
canicola
data
shown
endotheli
cell
respons
leptospira
wwwplosntdsorg
extracellular
bacteria
appar
devoid
actin
modifi
exotoxin
devoid
special
secret
system
util
mani
bacteri
pathogen
deliv
toxin
disrupt
host
cell
cytoskeleton
review
pathogen
leptospir
might
indirectli
target
cytoskeleton
via
cell
surfac
attach
mechan
coopt
host
cell
signal
achiev
result
decreas
cellular
adhes
ecm
rearrang
cytoskeleton
may
facilit
migrat
leptospira
endotheli
barrier
dissemin
site
inocul
explor
possibl
actin
rearrang
trigger
leptospira
infect
function
level
endotheli
cell
plate
chamber
slide
infect
moi
hour
hour
shown
figur
bacteria
clearli
adher
cell
extracellular
space
pathogen
bacteria
caus
dramat
signific
alter
cellular
morpholog
integr
cell
layer
nonpathogen
bacteria
earliest
chang
note
reduct
cortic
actin
cell
edg
less
defin
appear
gap
confluent
cell
layer
follow
loss
stress
fiber
round
cell
imag
shown
figur
cell
layer
confluenc
prior
infect
allow
better
visual
chang
individu
cell
exampl
cortic
actin
larg
disappear
cell
infect
l
interrogan
canicola
hour
postinfect
stress
fiber
disappear
cell
round
evid
hour
cell
larg
unaffect
time
point
infect
l
biflexa
patoc
figur
l
biflexa
endotheli
cell
respons
leptospira
wwwplosntdsorg
adher
mammalian
cell
cultur
less
effici
l
interrogan
shown
review
even
bacteri
contact
cell
facilit
centrifug
l
biflexa
caus
littl
disrupt
cellular
morpholog
cell
layer
integr
data
shown
although
subsequ
experi
perform
use
adher
cell
morpholog
chang
consist
chang
mrna
level
seen
use
lift
cell
microarray
experi
despit
alter
cellular
architectur
monolay
integr
decreas
endotheli
cell
viabil
found
sever
criteria
see
materi
method
even
infect
time
extend
long
hour
figur
disrupt
layer
howev
result
abil
pathogen
strain
cross
monolay
effici
nonpathogen
bacteria
figur
brief
period
endotheli
layer
prevent
signific
transmigr
bacteria
layer
rapidli
becam
essenti
irrelev
barrier
penetr
pathogen
bacteria
bacteri
count
lower
chamber
unaffect
whether
cell
plate
membran
leptospira
interrogan
shown
bind
proteoglycan
mammalian
cell
surfac
test
proteoglycan
synthesi
inhibitor
bxylosid
abil
decreas
damag
endotheli
cell
layer
caus
l
interrogan
canicola
bxylosid
inhibit
transfer
glycosaminoglycan
chain
protein
core
control
sugar
analog
agalactosid
test
parallel
shown
figur
inhibit
proteoglycan
synthesi
fulli
prevent
damag
endotheli
cell
layer
caus
l
interrogan
inhibit
glycosaminoglycan
chain
attach
significantli
affect
format
hole
cell
layer
caus
l
interrogan
canicola
assess
visual
measur
l
interrogan
penetr
cell
layer
data
shown
bxylosid
caus
reduct
l
interrogan
canicola
copenhageni
attach
cell
data
shown
abolish
bacteri
attach
consist
hypothesi
addit
nonproteoglycan
molecul
serv
substrat
l
interrogan
attach
cell
direct
bacteri
attach
cell
appear
requir
damag
endotheli
cell
layer
supernat
harvest
infect
cell
layer
infect
time
hr
steril
centrifug
filtrat
mm
filter
affect
endotheli
cell
layer
integr
data
shown
therefor
nonproteoglycan
cell
surfac
receptor
like
primarili
involv
respons
endotheli
cell
l
interrogan
attach
effort
identifi
host
cell
bacteri
cell
molecul
involv
interact
underway
note
public
report
sequenc
two
l
biflexa
patoc
strain
number
protein
predict
publish
l
interrogan
genom
present
l
biflexa
patoc
genom
includ
postul
potenti
adhesin
activ
includ
protein
contain
leucinerich
repeat
involv
mani
proteinprotein
interact
state
public
l
biflexa
genom
intrigu
cell
layer
treat
proteoglycan
synthesi
inhibitor
bxylosid
control
agalactosid
describ
prior
infect
l
interrogan
sv
copenhageni
hr
cell
layer
wash
fix
stain
phalloidinfitc
neither
reagent
significantli
reduc
disrupt
cell
layer
l
interrogan
alter
cell
morpholog
signific
gap
cell
seen
l
interrogan
present
transendotheli
cell
layer
migrat
significantli
affect
data
shown
consist
result
chondroitin
sulfat
b
inhibit
l
interrogan
attach
mammalian
cell
respect
also
effect
shown
endotheli
cell
respons
leptospira
wwwplosntdsorg
treponema
denticola
leucinerich
repeat
protein
lrra
identifi
adhesiontissu
penetr
factor
also
possibl
addit
compon
surfac
l
interrogan
l
biflexa
might
differ
effect
host
cell
point
howev
determin
critic
effect
l
interroganshost
cell
interact
report
remain
identifi
neither
bacteri
adhesin
host
substrat
necessarili
predict
sole
basi
primari
amino
acid
sequenc
sever
drug
current
use
human
report
endotheli
barrier
protect
function
use
antihypertens
therapeut
therapeut
purpos
well
therefor
test
four
differ
drug
differ
mechan
action
abil
prevent
damag
endotheli
layer
cultur
caus
l
interrogan
lisinopril
bind
competit
inhibit
angiotensin
bind
angiotensin
convert
enzym
ace
express
endotheli
cell
telmisartan
competit
inhibit
angiotensin
bind
receptor
dopamin
antagonist
cell
layer
permeabl
treatment
human
umbil
vein
endotheli
cell
huvec
vitro
well
vegfmedi
angiogenesi
vivo
prolifer
huvec
mm
vitro
furosemid
anion
transport
blocker
use
diuret
antihypertens
activ
consequ
use
control
expect
preserv
endotheli
layer
integr
telmisartan
furosemid
dopamin
protect
endotheli
layer
damag
due
l
interrogan
copenhageni
infect
lisinopril
nm
mm
mm
figur
repres
independ
experi
data
shown
sever
possibl
explan
includ
lisinopril
inhibit
l
interrogan
attach
cell
attach
unaffect
interact
bacteria
trigger
activ
signal
cascad
releas
mediat
whose
action
activ
inhibit
lisinopril
therefor
investig
possibl
lisinopril
might
prevent
figur
effect
specif
drug
protect
endotheli
barrier
function
damag
caus
l
interrogan
panel
b
endotheli
cell
layer
infect
l
interrogan
sv
copenhageni
l
biflexa
sv
patoc
describ
materi
method
except
prior
addit
bacteria
drug
lisinopril
telmisartan
dopamin
furosemid
ad
mm
micrograph
shown
panel
repres
three
experi
taken
hour
time
point
graph
panel
b
show
transmigr
leptospir
entir
hr
time
cours
shown
mean
standard
deviat
data
three
experi
statist
signific
determin
use
repeat
measur
anova
follow
bonferroni
multipl
comparison
test
well
cell
l
interrogan
vs
l
biflexa
l
interrogan
addit
vs
telmisartan
signific
l
interrogan
addit
vs
lisinopril
l
interrogan
telmisartan
vs
lisinopril
signific
differ
absenc
cell
drug
affect
bacteri
motil
attach
slabel
leptospir
cell
panel
c
data
shown
figur
lisinopril
concentr
effect
protect
endotheli
cell
layer
damag
due
l
interrogan
endotheli
cell
layer
infect
l
interrogan
sv
copenhageni
describ
materi
method
except
prior
addit
bacteria
drug
lisinopril
telmisartan
ad
concentr
indic
micrograph
taken
hour
time
point
lisinopril
mm
mm
nm
block
endotheli
disrupt
l
interrogan
lisinopril
nm
endotheli
cell
respons
leptospira
wwwplosntdsorg
endotheli
damag
block
l
interrogan
copenhageni
attach
cell
inhibit
adhes
slabel
bacteria
seen
even
concentr
lisinopril
fold
concentr
use
experi
figur
although
tempt
specul
cellsurfaceloc
ace
could
serv
receptor
l
interrogan
enzym
express
endotheli
cell
proxim
tubul
epitheli
cell
therefor
open
possibl
competit
lisinopril
consist
result
date
howev
inhibit
lisinopril
receptor
sar
viru
preced
ace
protein
serv
receptor
pathogen
also
possibl
effect
lisinopril
system
relat
ace
inhibit
instead
due
addit
effect
lisinopril
inhibit
isoprenoid
synthesi
requir
posttransl
modif
rho
gtpase
turn
regul
actin
cytoskeleton
turn
may
lead
increas
synthesi
protect
endotheli
function
face
varieti
insult
given
doxycyclin
also
endotheli
protect
effect
doxycyclin
effect
treat
leptospirosi
result
may
also
provid
start
point
investig
possibl
combinatori
therapeut
approach
reduct
endotheli
damag
consequ
organ
damag
human
popul
leptospirosi
outbreak
combinatori
approach
prove
use
anim
model
consider
focus
approach
treatment
human
leptospirosi
warrant
mm
dose
shown
figur
high
end
physiolog
relev
dose
rang
human
administr
antihypertens
patient
clinic
manifest
leptospirosi
would
contraind
depress
blood
pressur
level
would
potenti
lethal
howev
outbreak
situat
agent
could
potenti
help
reduc
endotheli
damag
administ
affect
popul
soon
outbreak
situat
recogn
prior
exposur
major
popul
pathogen
leptospira
speci
addit
protect
effect
lisinopril
maintain
even
dose
nm
well
within
rang
routin
use
human
figur
also
interest
investig
possibl
popul
basi
patient
lisinopril
fare
better
patient
therapi
leptospirosi
outbreak
reorgan
actin
cytoskeleton
indic
microarray
studi
phalloidin
stain
f
actin
essenti
pathogenesi
divers
bacteri
infect
pathogen
use
mani
differ
strategi
provok
chang
cellular
cytoskeleton
order
facilit
invas
tissu
invas
host
cell
evas
phagocytosi
review
differ
spirochet
treponema
denticola
produc
protein
msp
disrupt
actin
cytoskeleton
neutrophil
fibroblast
prevent
phagocytosi
bacterium
inhibit
cellular
migrat
requir
respond
repair
damag
caus
pathogen
host
respons
site
infect
activ
like
facilit
invas
colon
periodont
tissu
denticola
previou
work
anoth
laboratori
demonstr
l
interrogan
copenhageni
cross
mdck
canin
kidney
epitheli
cell
layer
cultur
rapidli
l
biflexa
patoc
without
signific
disrupt
cell
layer
actin
cytoskeleton
consist
result
experi
shown
also
observ
signific
damag
nrk
normal
rat
kidney
human
kidney
human
laryng
epitheli
cell
layer
infect
l
interrogan
canicola
l
interrogan
copenhageni
calcul
proport
bacteria
cross
cell
layer
differ
two
studi
protocol
account
replic
l
interrogan
canicola
copenhageni
cocultur
l
biflexa
patoc
replic
data
shown
thu
endotheli
cell
test
respond
differ
bacteria
mdck
epitheli
cell
result
first
suggest
mechan
disrupt
actin
dynam
bacteri
attach
cell
surfac
thu
l
interrogan
shown
secret
toxin
modifi
actin
bacteria
abl
manipul
actin
cytoskeleton
indirectli
even
pore
form
toxin
activ
report
leptospira
appear
larg
effect
endotheli
cell
viabl
throughout
experi
leptospir
may
abl
establish
dissemin
infect
part
due
bind
bacteria
one
mammalian
cell
surfac
receptor
turn
regul
dynam
actin
cytoskeleton
mammalian
cell
deciph
role
mechan
behind
actin
rearrang
respons
pathogen
leptospira
provid
insight
mechan
leptospir
use
dissemin
differ
organ
host
caus
infect
diseas
provid
possibl
avenu
therapeut
intervent
conjunct
antimicrobi
therapi
